EOLS
Evolus, Inc.
Price Chart
Latest Quote
$6.63
-0.11 (-1.63%)
Current Price
| Previous Close | $6.74 |
| Open | $6.90 |
| Day High | $6.90 |
| Day Low | $6.53 |
| Volume | 1,101,794 |
Stock Information
| Shares Outstanding | 65.85M |
| Total Debt | $164.90M |
| Cash Equivalents | $49.79M |
| Revenue | $301.79M |
| Net Income | $-43.42M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $436.62M |
| EPS (TTM) | $-0.66 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $551.73M |
| Sales | $301.79M |
| Income | $-43.42M |
| Book/sh | $-0.44 |
| Cash/sh | $0.76 |
| Employees | 350 |
Financial Ratios
| Quick Ratio | 1.50 |
| Current Ratio | 2.04 |
Returns & Margins
| ROA | -9.06% |
| Gross Margin | 66.05% |
| Operating Margin | -9.38% |
| Profit Margin | -14.39% |
Ownership
| Insider Ownership | 14.68% |
| Institutional Ownership | 70.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 27.63 |
| P/S | 1.45 |
| P/B | -15.17 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $14.67 |
Technical Indicators
| SMA20 | $6.51 |
| SMA50 | $5.93 |
| SMA200 | $5.91 |
| RSI | 51.74 |
| ATR | 0.3429 |
| Shares Float | 50.04M |
| Short Float | 9.32% |
| Short Ratio | 6.37 |
| Volatility | 1.33 |
| Rel Volume | 1.43 |
Performance History
| Week | +1.84% |
| Month | +3.11% |
| Quarter | +36.42% |
| 6 Months | -8.17% |
| YTD | -1.34% |
| Year | -28.32% |
| 3 Years | -17.84% |
| 5 Years | -46.23% |
| 10 Years | -42.35% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $6.63 | 1,101,800 |
| 2026-06-17 | $6.74 | 1,040,100 |
| 2026-06-16 | $6.63 | 806,700 |
| 2026-06-15 | $6.75 | 904,200 |
| 2026-06-12 | $6.73 | 635,600 |
| 2026-06-11 | $6.51 | 631,000 |
| 2026-06-10 | $6.72 | 670,800 |
| 2026-06-09 | $6.70 | 774,700 |
| 2026-06-08 | $6.68 | 750,000 |
| 2026-06-05 | $6.67 | 706,600 |
| 2026-06-04 | $6.60 | 1,184,100 |
| 2026-06-03 | $6.03 | 497,400 |
| 2026-06-02 | $6.17 | 521,300 |
| 2026-06-01 | $6.52 | 874,400 |
| 2026-05-29 | $6.56 | 826,200 |
| 2026-05-28 | $6.57 | 976,700 |
| 2026-05-27 | $6.18 | 513,700 |
| 2026-05-26 | $6.25 | 868,400 |
| 2026-05-22 | $6.09 | 627,500 |
| 2026-05-21 | $6.45 | 531,600 |
| 2026-05-20 | $6.59 | 777,600 |
| 2026-05-19 | $6.43 | 660,800 |
About Evolus, Inc.
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
đ° Latest News
3 High-Growth Insider-Owned Companies With Earnings Surging Up To 80%
Simply Wall St. âĸ 2026-05-15T11:35:42Z
Evolus, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-05T00:23:54Z
Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-04T23:30:04Z
Evolus Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-04T22:17:52Z
Evolus (EOLS) Q2 2025 Earnings Call Transcript
Motley Fool âĸ 2026-05-04T20:34:49Z
How The Evolus (EOLS) Story Is Shifting As Analysts Reset Growth And Valuation Assumptions
Simply Wall St. âĸ 2026-04-26T02:09:11Z
April 2026's Leading Growth Stocks With Insider Confidence
Simply Wall St. âĸ 2026-04-16T17:36:05Z
Evolus Targets Double-Digit Growth, Full-Year Profitability at Needham Healthcare Conference
MarketBeat âĸ 2026-04-16T04:02:44Z
How The Evolus (EOLS) Investment Story Is Shifting After Softer Guidance And Target Cuts
Simply Wall St. âĸ 2026-04-11T13:08:23Z
Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization
Exec Edge âĸ 2026-04-07T19:35:47Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $95,671,000 | $80,292,000 | $60,825,000 | $55,112,000 |
| Cost Of Revenue | $100,069,000 | $83,970,000 | $64,514,000 | $58,842,000 |
| Total Revenue | $297,176,000 | $266,274,000 | $202,085,000 | $148,616,000 |
| Operating Revenue | $297,176,000 | $266,274,000 | $202,085,000 | $148,616,000 |
| Expenses | ||||
| Interest Expense | $19,694,000 | $18,735,000 | $13,832,000 | $9,097,000 |
| Total Expenses | $334,776,000 | $293,509,000 | $247,061,000 | $208,191,000 |
| Other Income Expense | $4,399,000 | $-7,049,000 | $-3,561,000 | $-5,764,000 |
| Other Non Operating Income Expenses | $5,842,000 | $-7,049,000 | $-3,561,000 | $-5,764,000 |
| Net Non Operating Interest Income Expense | $-17,763,000 | $-15,472,000 | $-12,972,000 | $-8,978,000 |
| Interest Expense Non Operating | $19,694,000 | $18,735,000 | $13,832,000 | $9,097,000 |
| Operating Expense | $234,707,000 | $209,539,000 | $182,547,000 | $149,349,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-51,641,000 | $-50,420,000 | $-61,685,000 | $-74,412,000 |
| Net Interest Income | $-17,763,000 | $-15,472,000 | $-12,972,000 | $-8,978,000 |
| Interest Income | $1,931,000 | $3,263,000 | $860,000 | $119,000 |
| Normalized Income | $-50,501,030 | $-50,420,000 | $-61,685,000 | $-74,412,000 |
| Net Income From Continuing And Discontinued Operation | $-51,641,000 | $-50,420,000 | $-61,685,000 | $-74,412,000 |
| Total Operating Income As Reported | $-32,662,000 | $-34,411,000 | $-49,233,000 | $-65,330,000 |
| Net Income Common Stockholders | $-51,641,000 | $-50,420,000 | $-61,685,000 | $-74,412,000 |
| Net Income | $-51,641,000 | $-50,420,000 | $-61,685,000 | $-74,412,000 |
| Net Income Including Noncontrolling Interests | $-51,641,000 | $-50,420,000 | $-61,685,000 | $-74,412,000 |
| Net Income Continuous Operations | $-51,641,000 | $-50,420,000 | $-61,685,000 | $-74,412,000 |
| Pretax Income | $-50,964,000 | $-49,756,000 | $-61,509,000 | $-74,317,000 |
| Special Income Charges | $-1,443,000 | $0 | $0 | $0 |
| Interest Income Non Operating | $1,931,000 | $3,263,000 | $860,000 | $119,000 |
| Operating Income | $-37,600,000 | $-27,235,000 | $-44,976,000 | $-59,575,000 |
| Depreciation Amortization Depletion Income Statement | $4,345,000 | $2,342,000 | $2,178,000 | $767,000 |
| Depreciation And Amortization In Income Statement | $4,345,000 | $2,342,000 | $2,178,000 | $767,000 |
| Gross Profit | $197,107,000 | $182,304,000 | $137,571,000 | $89,774,000 |
| Per Share | ||||
| Diluted EPS | $-0.80 | $-0.81 | $-1.08 | $-1.33 |
| Basic EPS | $-0.80 | $-0.81 | $-1.08 | $-1.33 |
| Other | ||||
| Tax Effect Of Unusual Items | $-303,030 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-21,084,000 | $-25,001,000 | $-41,810,000 | $-60,723,000 |
| Total Unusual Items | $-1,443,000 | $0 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $-1,443,000 | $0 | $0 | $0 |
| Reconciled Depreciation | $8,743,000 | $6,020,000 | $5,867,000 | $4,497,000 |
| EBITDA (Bullshit earnings) | $-22,527,000 | $-25,001,000 | $-41,810,000 | $-60,723,000 |
| EBIT | $-31,270,000 | $-31,021,000 | $-47,677,000 | $-65,220,000 |
| Diluted Average Shares | $64,469,000 | $62,246,914 | $56,919,000 | $56,065,000 |
| Basic Average Shares | $64,469,000 | $62,246,914 | $56,919,000 | $56,065,000 |
| Diluted NI Availto Com Stockholders | $-51,641,000 | $-50,420,000 | $-61,685,000 | $-74,412,000 |
| Tax Provision | $677,000 | $664,000 | $176,000 | $95,000 |
| Restructuring And Mergern Acquisition | $1,443,000 | $0 | $0 | - |
| Research And Development | $9,576,000 | $9,172,000 | $15,425,000 | $6,742,000 |
| Selling General And Administration | $220,786,000 | $198,025,000 | $164,944,000 | $141,840,000 |
| Other Special Charges | - | - | - | $2,000,000 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-92,354,000 | $-64,440,000 | $-89,007,000 | $-51,306,000 |
| Total Assets | $225,868,000 | $232,569,000 | $188,998,000 | $177,983,000 |
| Total Non Current Assets | $82,951,000 | $81,227,000 | $76,577,000 | $77,181,000 |
| Other Non Current Assets | $1,199,000 | $858,000 | $409,000 | $2,813,000 |
| Goodwill And Other Intangible Assets | $69,248,000 | $69,962,000 | $68,318,000 | $69,805,000 |
| Other Intangible Assets | $48,040,000 | $48,754,000 | $47,110,000 | $48,597,000 |
| Current Assets | $142,917,000 | $151,342,000 | $112,421,000 | $100,802,000 |
| Other Current Assets | $3,674,000 | $1,201,000 | $2,356,000 | $1,678,000 |
| Prepaid Assets | $3,757,000 | $3,349,000 | $5,700,000 | $3,902,000 |
| Inventory | $26,963,000 | $12,158,000 | $10,998,000 | $18,852,000 |
| Receivables | $54,697,000 | $47,682,000 | $30,529,000 | $22,448,000 |
| Accounts Receivable | $54,697,000 | $47,682,000 | $30,529,000 | $22,448,000 |
| Allowance For Doubtful Accounts Receivable | $-5,289,000 | $-2,714,000 | $-1,490,000 | $-2,050,000 |
| Gross Accounts Receivable | $59,986,000 | $50,396,000 | $32,019,000 | $24,498,000 |
| Cash Cash Equivalents And Short Term Investments | $53,826,000 | $86,952,000 | $62,838,000 | $53,922,000 |
| Cash And Cash Equivalents | $53,826,000 | $86,952,000 | $62,838,000 | $53,922,000 |
| Debt | ||||
| Net Debt | $92,270,000 | $34,554,000 | $57,521,000 | $17,957,000 |
| Total Debt | $154,996,000 | $129,979,000 | $126,546,000 | $74,423,000 |
| Long Term Debt And Capital Lease Obligation | $152,467,000 | $128,261,000 | $125,169,000 | $73,103,000 |
| Long Term Debt | $146,096,000 | $121,506,000 | $120,359,000 | $71,879,000 |
| Current Debt And Capital Lease Obligation | $2,529,000 | $1,718,000 | $1,377,000 | $1,320,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $248,974,000 | $227,047,000 | $209,687,000 | $159,484,000 |
| Total Non Current Liabilities Net Minority Interest | $173,669,000 | $164,087,000 | $161,396,000 | $112,975,000 |
| Tradeand Other Payables Non Current | $1,515,000 | $2,270,000 | $0 | $0 |
| Non Current Deferred Liabilities | $28,000 | $6,000 | $27,000 | $22,000 |
| Non Current Deferred Taxes Liabilities | $28,000 | $6,000 | $27,000 | $22,000 |
| Current Liabilities | $75,305,000 | $62,960,000 | $48,291,000 | $46,509,000 |
| Other Current Liabilities | $1,302,000 | - | - | - |
| Current Deferred Liabilities | $11,548,000 | $14,454,000 | $11,033,000 | $9,011,000 |
| Payables And Accrued Expenses | $59,926,000 | $46,788,000 | $35,881,000 | $36,178,000 |
| Payables | $35,883,000 | $20,451,000 | $13,101,000 | $15,395,000 |
| Accounts Payable | $23,360,000 | $9,236,000 | $4,271,000 | $8,935,000 |
| Current Notes Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $-23,106,000 | $5,522,000 | $-20,689,000 | $18,499,000 |
| Total Equity Gross Minority Interest | $-23,106,000 | $5,522,000 | $-20,689,000 | $18,499,000 |
| Stockholders Equity | $-23,106,000 | $5,522,000 | $-20,689,000 | $18,499,000 |
| Gains Losses Not Affecting Retained Earnings | $-156,000 | $-905,000 | $-427,000 | $-337,000 |
| Other Equity Adjustments | $-156,000 | $-905,000 | $-427,000 | $-337,000 |
| Retained Earnings | $-661,040,000 | $-609,399,000 | $-558,979,000 | $-497,294,000 |
| Other | ||||
| Ordinary Shares Number | $65,008,183 | $63,497,548 | $57,820,621 | $56,260,570 |
| Share Issued | $65,008,183 | $63,497,548 | $57,820,621 | $56,260,570 |
| Tangible Book Value | $-92,354,000 | $-64,440,000 | $-89,007,000 | $-51,306,000 |
| Invested Capital | $122,990,000 | $127,028,000 | $99,670,000 | $90,378,000 |
| Working Capital | $67,612,000 | $88,382,000 | $64,130,000 | $54,293,000 |
| Capital Lease Obligations | $8,900,000 | $8,473,000 | $6,187,000 | $2,544,000 |
| Total Capitalization | $122,990,000 | $127,028,000 | $99,670,000 | $90,378,000 |
| Additional Paid In Capital | $638,089,000 | $615,825,000 | $538,716,000 | $516,129,000 |
| Capital Stock | $1,000 | $1,000 | $1,000 | $1,000 |
| Common Stock | $1,000 | $1,000 | $1,000 | $1,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Dueto Related Parties Non Current | $19,659,000 | $33,550,000 | $36,200,000 | $39,850,000 |
| Long Term Capital Lease Obligation | $6,371,000 | $6,755,000 | $4,810,000 | $1,224,000 |
| Current Deferred Revenue | $11,548,000 | $14,454,000 | $11,033,000 | $9,011,000 |
| Current Capital Lease Obligation | $2,529,000 | $1,718,000 | $1,377,000 | $1,320,000 |
| Current Accrued Expenses | $24,043,000 | $26,337,000 | $22,780,000 | $20,783,000 |
| Dueto Related Parties Current | $12,523,000 | $11,215,000 | $8,830,000 | $6,460,000 |
| Goodwill | $21,208,000 | $21,208,000 | $21,208,000 | $21,208,000 |
| Net PPE | $12,504,000 | $10,407,000 | $7,850,000 | $4,563,000 |
| Accumulated Depreciation | $-4,759,000 | $-3,523,000 | $-2,400,000 | - |
| Gross PPE | $17,263,000 | $13,930,000 | $10,250,000 | $4,563,000 |
| Leases | $6,100,000 | $3,574,000 | $2,212,000 | - |
| Other Properties | $7,902,000 | $7,637,000 | $5,844,000 | $4,563,000 |
| Machinery Furniture Equipment | $3,261,000 | $2,719,000 | $2,194,000 | - |
| Properties | $0 | $0 | $0 | - |
| Treasury Shares Number | - | - | $0 | - |
| Non Current Accrued Expenses | - | - | - | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | - | - |
| Other Short Term Investments | - | - | - | - |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-50,717,000 | $-22,822,000 | $-35,635,000 | $-87,851,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-42,265,000 | $-17,999,000 | $-34,008,000 | $-84,912,000 |
| Cash Flow From Continuing Operating Activities | $-42,265,000 | $-17,999,000 | $-34,008,000 | $-84,912,000 |
| Operating Gains Losses | - | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-8,452,000 | $-4,823,000 | $-1,627,000 | $-2,939,000 |
| Investing Cash Flow | $-8,452,000 | $-4,823,000 | $-1,627,000 | $-2,939,000 |
| Cash Flow From Continuing Investing Activities | $-8,452,000 | $-4,823,000 | $-1,627,000 | $-2,939,000 |
| Capital Expenditure Reported | $-5,011,000 | $-3,351,000 | $-1,154,000 | $-1,321,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $51,211,000 | $0 | $0 |
| Financing Cash Flow | $17,337,000 | $47,414,000 | $44,641,000 | $-4,146,000 |
| Cash Flow From Continuing Financing Activities | $17,337,000 | $47,414,000 | $44,641,000 | $-4,146,000 |
| Net Other Financing Charges | $-8,812,000 | $-8,679,000 | $-5,590,000 | $-4,685,000 |
| Net Common Stock Issuance | $0 | $51,211,000 | $0 | $0 |
| Common Stock Issuance | $0 | $51,211,000 | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-15,000 | $0 | $0 | $0 |
| Issuance Of Debt | $25,000,000 | $0 | $50,000,000 | $0 |
| Interest Paid Supplemental Data | $14,792,000 | $17,545,000 | $12,708,000 | $7,999,000 |
| Income Tax Paid Supplemental Data | $1,215,000 | $235,000 | $117,000 | $76,000 |
| End Cash Position | $53,826,000 | $86,952,000 | $62,838,000 | $53,922,000 |
| Beginning Cash Position | $86,952,000 | $62,838,000 | $53,922,000 | $146,256,000 |
| Effect Of Exchange Rate Changes | $254,000 | $-478,000 | $-90,000 | $-337,000 |
| Changes In Cash | $-33,380,000 | $24,592,000 | $9,006,000 | $-91,997,000 |
| Proceeds From Stock Option Exercised | $1,164,000 | $4,882,000 | $231,000 | $539,000 |
| Net Issuance Payments Of Debt | $24,985,000 | $0 | $50,000,000 | $0 |
| Net Long Term Debt Issuance | $24,985,000 | $0 | $50,000,000 | $0 |
| Long Term Debt Payments | $-15,000 | $0 | $0 | $0 |
| Long Term Debt Issuance | $25,000,000 | $0 | $50,000,000 | $0 |
| Net PPE Purchase And Sale | $-3,441,000 | $-1,472,000 | $-473,000 | $-1,618,000 |
| Purchase Of PPE | $-3,441,000 | $-1,472,000 | $-473,000 | $-1,618,000 |
| Change In Working Capital | $-22,476,000 | $-6,640,000 | $-5,895,000 | $-34,251,000 |
| Change In Other Current Liabilities | $-758,000 | $-716,000 | $-907,000 | $-977,000 |
| Change In Other Current Assets | $-2,469,000 | $706,000 | $-864,000 | $4,854,000 |
| Change In Payables And Accrued Expense | $3,739,000 | $7,369,000 | $3,002,000 | $-19,231,000 |
| Change In Accrued Expense | $-6,364,000 | $6,978,000 | $4,019,000 | $-20,199,000 |
| Change In Payable | $10,103,000 | $391,000 | $-1,017,000 | $968,000 |
| Change In Account Payable | $10,103,000 | $391,000 | $-1,017,000 | $968,000 |
| Change In Prepaid Assets | $-355,000 | $2,351,000 | $-1,798,000 | $1,180,000 |
| Change In Inventory | $-11,124,000 | $3,252,000 | $4,193,000 | $-10,688,000 |
| Change In Receivables | $-11,509,000 | $-19,602,000 | $-9,521,000 | $-9,389,000 |
| Changes In Account Receivables | $-11,509,000 | $-19,602,000 | $-9,521,000 | $-9,389,000 |
| Other Non Cash Items | $-4,125,000 | $8,359,000 | $9,802,000 | $6,841,000 |
| Stock Based Compensation | $20,698,000 | $22,254,000 | $16,458,000 | $10,833,000 |
| Provisionand Write Offof Assets | $6,515,000 | $2,449,000 | $1,440,000 | $1,598,000 |
| Deferred Tax | $21,000 | $-21,000 | $5,000 | $-18,000 |
| Deferred Income Tax | $21,000 | $-21,000 | $5,000 | $-18,000 |
| Depreciation Amortization Depletion | $8,743,000 | $6,020,000 | $5,867,000 | $4,497,000 |
| Depreciation And Amortization | $8,743,000 | $6,020,000 | $5,867,000 | $4,497,000 |
| Depreciation | $8,743,000 | $6,020,000 | $5,867,000 | $4,497,000 |
| Net Income From Continuing Operations | $-51,641,000 | $-50,420,000 | $-61,685,000 | $-74,412,000 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Sale Of Investment | - | - | - | $0 |
| Amortization Of Securities | - | - | - | $0 |
| Purchase Of Investment | - | - | - | - |
Fetched: 2026-06-17